We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

April 20, 2018

Kessman v. Myriad Genetics et al

Track this case

Case Number:

2:18-cv-00336

Court:

Utah

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Dale A. Kimball

Firms

Companies

Sectors & Industries:

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. March 25, 2019

    Myriad Genetics Ditches Medicare Overbilling Stock-Drop Suit

    Myriad Genetics Inc. and its directors on Monday shook a proposed securities class action alleging a fraudulent billing of Medicare after a Utah federal judge ruled the suing investor failed to plead that the company's billing was illegal or even an outlier in the industry.

2 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS